Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome

J. A. Velosa, Vicente Torres

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In this paper the authors discuss the effects of nonsteroidal antiinflammatory drugs on proteinuria and the specific risks of these drugs in patients with nephrotic syndrome. The authors summarize the results of a prospective uncontrolled trial of meclofenamate in severe steroid-resistant nephrotic syndrome secondary to focal glomerular sclerosis and idiopathic membranous nephropathy. This study examined the effect of meclofenamate on proteinuria, serum albumin levels, serum cholesterol, serum triglycerides, renal function, BP, liver function tests, and hemotologic selective use and careful supervision of NSAIDs in the nephrotic syndrome.

Original languageEnglish (US)
Pages (from-to)345-350
Number of pages6
JournalAmerican Journal of Kidney Diseases
Volume8
Issue number5
StatePublished - 1986

Fingerprint

Nephrotic Syndrome
Meclofenamic Acid
Anti-Inflammatory Agents
Steroids
Proteinuria
Pharmaceutical Preparations
Membranous Glomerulonephritis
Liver Function Tests
Sclerosis
Non-Steroidal Anti-Inflammatory Agents
Serum
Serum Albumin
Triglycerides
Cholesterol
Kidney

ASJC Scopus subject areas

  • Nephrology

Cite this

Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome. / Velosa, J. A.; Torres, Vicente.

In: American Journal of Kidney Diseases, Vol. 8, No. 5, 1986, p. 345-350.

Research output: Contribution to journalArticle

@article{65969749682343f9aa2fde30e0451bcc,
title = "Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome",
abstract = "In this paper the authors discuss the effects of nonsteroidal antiinflammatory drugs on proteinuria and the specific risks of these drugs in patients with nephrotic syndrome. The authors summarize the results of a prospective uncontrolled trial of meclofenamate in severe steroid-resistant nephrotic syndrome secondary to focal glomerular sclerosis and idiopathic membranous nephropathy. This study examined the effect of meclofenamate on proteinuria, serum albumin levels, serum cholesterol, serum triglycerides, renal function, BP, liver function tests, and hemotologic selective use and careful supervision of NSAIDs in the nephrotic syndrome.",
author = "Velosa, {J. A.} and Vicente Torres",
year = "1986",
language = "English (US)",
volume = "8",
pages = "345--350",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome

AU - Velosa, J. A.

AU - Torres, Vicente

PY - 1986

Y1 - 1986

N2 - In this paper the authors discuss the effects of nonsteroidal antiinflammatory drugs on proteinuria and the specific risks of these drugs in patients with nephrotic syndrome. The authors summarize the results of a prospective uncontrolled trial of meclofenamate in severe steroid-resistant nephrotic syndrome secondary to focal glomerular sclerosis and idiopathic membranous nephropathy. This study examined the effect of meclofenamate on proteinuria, serum albumin levels, serum cholesterol, serum triglycerides, renal function, BP, liver function tests, and hemotologic selective use and careful supervision of NSAIDs in the nephrotic syndrome.

AB - In this paper the authors discuss the effects of nonsteroidal antiinflammatory drugs on proteinuria and the specific risks of these drugs in patients with nephrotic syndrome. The authors summarize the results of a prospective uncontrolled trial of meclofenamate in severe steroid-resistant nephrotic syndrome secondary to focal glomerular sclerosis and idiopathic membranous nephropathy. This study examined the effect of meclofenamate on proteinuria, serum albumin levels, serum cholesterol, serum triglycerides, renal function, BP, liver function tests, and hemotologic selective use and careful supervision of NSAIDs in the nephrotic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0022887934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022887934&partnerID=8YFLogxK

M3 - Article

C2 - 3788972

AN - SCOPUS:0022887934

VL - 8

SP - 345

EP - 350

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5

ER -